Amber Liu is a Business Developer at Oncode Institute. With a clinical pharmacy background from the University of Toronto, she has taken her patient-centric perspective in scouting for novel innovations in life sciences with high impact potential and supported their commercial development. Prior to Oncode, she developed funding strategies, business cases, conducted market assessments and new business development activities at strategic funding consultancies in The Netherlands. While at a health tech accelerator, her focus was on validating the business case of a given innovation and testing the value proposition with end-users. At Oncode, Amber facilitates the translation of research into clinical applications through identification and evaluation of innovative technologies or new therapies. This involves developing and implementing effective valorization strategies, fostering strong stakeholder relationships, and proactively engaging industry partners to pursue collaborative opportunities.